cinacalcet has been researched along with Multiple Endocrine Neoplasia Type 1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carratù, AC; Colao, A; De Luca Di Roseto, C; Del Prete, M; Di Sarno, A; Di Somma, C; Esposito, R; Faggiano, A; Marciello, F; Marotta, V; Ramundo, V | 1 |
| Brandi, ML; Cianferotti, L; Cioppi, F; Colao, A; Faggiano, A; Ferolla, P; Giusti, F; Gronchi, G; Masi, L | 1 |
| Banti, C; Cetani, F; Chiavistelli, S; Cianferotti, L; Marcocci, C; Pinchera, A; Saponaro, F; Viccica, G; Vignali, E | 1 |
| Beck-Peccoz, P; Corbetta, S; Eller-Vainicher, C; Ermetici, F; Filopanti, M; Olgiati, L; Persani, L; Spada, A; Verga, U | 1 |
| Amedei, A; Brandi, ML; Cilotti, A; Cioppi, F; Falchetti, A; Masi, L; Tonelli, F; Vagelli, L; Vaggelli, L | 1 |
2 trial(s) available for cinacalcet and Multiple Endocrine Neoplasia Type 1
| Article | Year |
|---|---|
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
Topics: Adenoma; Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Longitudinal Studies; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Young Adult | 2016 |
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
Topics: Adenoma; Adult; Amino Acid Substitution; Arginine; Calcimimetic Agents; Cinacalcet; Cross-Over Studies; Double-Blind Method; Female; Glycine; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroid Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Receptors, Calcium-Sensing; Treatment Outcome; Young Adult | 2012 |
3 other study(ies) available for cinacalcet and Multiple Endocrine Neoplasia Type 1
| Article | Year |
|---|---|
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Middle Aged; Mothers; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Nuclear Family; Parathyroid Hormone; Pedigree; Phosphorus; Treatment Outcome | 2013 |
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
Topics: Aged; Aged, 80 and over; Biomarkers; Cinacalcet; Contraindications; Drug Labeling; European Union; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Maintenance Chemotherapy; Membrane Transport Modulators; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic; Prospective Studies; Receptors, Calcium-Sensing; Severity of Illness Index | 2012 |
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroid Hormone | 2008 |